PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Francesco Chiodo Selected Research

Highly Active Antiretroviral Therapy (HAART)

01/2006	Bladder carcinoma and HIV infection during the highly active antiretroviral therapy era: A rare, but intriguing association. Two case reports and literature review.
05/2004	[Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)]
10/2003	AIDS-associated Cryptococcus infection before and after the highly active antiretroviral therapy era: emerging management problems.
08/2003	AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
08/2003	Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management.
05/2003	Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy.
04/2003	[Osteonecrosis in HIV-infected patients and its correlation with highly active antiretroviral therapy (HAART)]
12/2002	Dual Candida albicans and Cryptococcus neoformans fungaemia in an AIDS presenter: a unique disease association in the highly active antiretroviral therapy (HAART) era.
11/2002	Three to seven concurrent AIDS-defining disorders at first hospitalization of AIDS presenters as an unexpected emerging feature during the era of highly active antiretroviral therapy.
11/2002	Subclinical hypothyroidism in HIV-infected patients receiving highly active antiretroviral therapy.
06/2002	[Effects induced by the introduction of highly active antiretroviral therapy (HAART) on disseminated bacterial infection during HIV disease]
02/2002	Enteric and disseminated Campylobacter species infection during HIV disease: a persisting but significantly modified association in the HAART era.

Articles by Research Topic

Disease

5	Acquired Immunodeficiency Syndrome (AIDS) 10/2003 - 11/2002
3	Infection 10/2003 - 02/2002
2	HIV Infections (HIV Infection) 01/2006 - 07/2003
1	Carcinoma (Carcinomatosis) 01/2006
1	Pulmonary Tuberculosis 01/2006
1	Hepatitis 01/2006
1	Central Nervous System Infections (Central Nervous System Infection) 06/2005
1	Arthritis (Polyarthritis) 01/2005
1	Hypertriglyceridemia 07/2004
1	Lipodystrophy 05/2004
1	Meningitis 01/2004
1	Lymphoma (Lymphomas) 09/2003
1	Kaposi Sarcoma (Kaposi's Sarcoma) 08/2003
1	Neoplasms (Cancer) 08/2003
1	Endocarditis 07/2003
1	Discoid Lupus Erythematosus 05/2003
1	Osteonecrosis (Kienbock's Disease) 04/2003
1	Hypothyroidism 11/2002
1	Bacterial Infections (Bacterial Infection) 06/2002

Drug/Important Bio-Agent (IBA)

2	linezolid (Zyvox)FDA Link 06/2005 - 01/2005
1	Ribavirin (Virazole)FDA LinkGeneric 01/2006
1	Interferon-alpha (Interferon Alfa)FDA Link 01/2006
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2005
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)FDA Link 07/2004
1	EstersIBA 07/2004
1	Propofol (Diprivan)FDA LinkGeneric 01/2004
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2004
1	rituximab (Mabthera)FDA Link 09/2003
1	Ampicillin (Omnipen)FDA LinkGeneric 07/2003
1	Gentamicins (Gentamicin)FDA LinkGeneric 07/2003
1	TeicoplaninIBA 07/2003

Therapy/Procedure

12	Highly Active Antiretroviral Therapy (HAART) 01/2006 - 02/2002